Liverpool
has significant expertise in biomanufacturing. With over 80 core life science
companies in the region and an equivalent number of non-core speciality
companies operating in the life science value chain, there is a critical
mass to foster cluster synergy and growth.
The sector employs over 4000 people directly, and turns over in excess of
£1/4 billion p.a. (397 million euro).
A dedicated Biosciences Centre and Incubator unit has been established at
the
University
of Liverpool with state of the art facilities and dedicated business
support provided by the
Merseybio.
Liverpool will also be the location for the UK's first National Biomanufacturing
Centre.
Location Drivers
| • |
Experienced Clinical Trials Centre with large and stable patient registers |
| • |
Business and Science Park developments |
| • |
An outstanding knowledge infrastructure provided by the universities with expertise in pharmacology, biological and biomedical sciences and chemistry. Specialist support for business provided through www.merseybio.com and Pharmhouse |
| • |
Up to 35% financial assistance for capital investment projects - the highest in the UK |
| • |
Liverpool has Grade 5 research departments in Pharmacology, Veterinary Science, Infection & Immunology, Clinical Laboratory Science, Cancer Studies & Chemistry andthe only 5* rated Physiology department in the country |
| • |
National Biomanufacturing Centre based in Speke |
| • |
Dedicated Incubator for biotechnology businesses |
| • |
Industry support through well networked partnerships |
| • |
A substantial, established and synergistic regional life science sector |
